Evidence map›Paper›PMID 41402259›Full record

ArticleNature communications2025

Cascades of effectiveness of next-generation insecticide-treated nets against malaria, from entomological trials to real-life conditions.

Clara Champagne, Jeanne Lemant, Alphonce Assenga, Ummi A Kibondo, Ruth G Lekundayo, Emmanuel Mbuba, Jason Moore, Joseph B Muganga, Watson S Ntabaliba, Olukayode G Odufuwa and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Estimating mosquito bionomics parameters with a hierarchical Bayesian model.Current research in parasitology & vector-borne diseases · 2026
    Article
  6. Comparative malaria impact of chlorfenapyr-α-cypermethrin netsCurrent research in parasitology & vector-borne diseases · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Clara ChampagneSwiss Tropical and Public Health Institute, Allschwil, Switzerland. clara.champagne@swisstph.ch.ORCID http://orcid.org/0000-0002-0369-6758
Jeanne LemantSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID http://orcid.org/0000-0003-1522-0025
Alphonce AssengaIfakara Health Institute, Bagamoyo, Tanzania.ORCID http://orcid.org/0009-0001-8967-3310
Ummi A KibondoIfakara Health Institute, Bagamoyo, Tanzania.ORCID http://orcid.org/0000-0003-3390-4738
Ruth G LekundayoIfakara Health Institute, Bagamoyo, Tanzania.
Emmanuel MbubaSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Jason MooreSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Joseph B MugangaIfakara Health Institute, Bagamoyo, Tanzania.
Watson S NtabalibaIfakara Health Institute, Bagamoyo, Tanzania.
Olukayode G OdufuwaSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Johnson Kyeba SwaiSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Maria AlexaSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID http://orcid.org/0000-0002-5612-9677
Roland GoersSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Monica GolumbeanuSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID http://orcid.org/0000-0002-8459-9983
Nakul ChitnisSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID http://orcid.org/0000-0002-1103-9141
Amanda RossSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Raphael N'GuessanLondon School of Hygiene and Tropical Medicine, Department of Disease Control, London, UK.
Sarah MooreSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID http://orcid.org/0000-0002-0938-6654
Emilie PothinSwiss Tropical and Public Health Institute, Allschwil, Switzerland.

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-068864Gates Foundation INV-025569Gates Foundation INV-030449
6 · The paper itself

Abstract

As insecticide resistance spreads in Africa, next-generation insecticide-treated nets (ITNs) are increasingly being deployed to protect vulnerable populations against malaria. While these nets provide greater entomological efficacy against resistant mosquitoes, their effectiveness against malaria transmission also depends on other factors, such as durability, access, usage, and activity patterns of hosts and vectors. Here, we quantify the impact of two next-generation ITNs, namely Interceptor®G2 (chlorfenapyr-pyrethroid) and Olyset® Plus (piperonyl butoxide-pyrethroid), in a cascade from entomological efficacy to population-level effectiveness. We use a mathematical model that we parameterize with entomological data and validate against results from randomized controlled trials. We found that, beyond entomological factors, operational factors including functional survival, ITN use and in-bed exposure critically impact ITN effectiveness overall and per ITN types. Our results obtained for Tanzania can be extended to other contexts in a dashboard allowing users to explore product selection based on setting-specific factors that influence ITN effectiveness.

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsMalariaMosquito ControlAnimalsHumansInsecticide ResistanceModels, TheoreticalMosquito VectorsPyrethrinsTanzaniaInsecticidesPyrethrins

Identifiers

PMID41402259
PMCPMC12708653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.